X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ALKEM LABORATORIES - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ALKEM LABORATORIES DIVIS LABORATORIES/
ALKEM LABORATORIES
 
P/E (TTM) x 28.7 - - View Chart
P/BV x 5.0 7.3 67.7% View Chart
Dividend Yield % 1.0 0.6 169.0%  

Financials

 DIVIS LABORATORIES   ALKEM LABORATORIES
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-17
ALKEM LABORATORIES
Mar-16
DIVIS LABORATORIES/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,2221,589 76.9%   
Low Rs7841,232 63.6%   
Sales per share (Unadj.) Rs153.1417.5 36.7%  
Earnings per share (Unadj.) Rs39.956.3 71.0%  
Cash flow per share (Unadj.) Rs44.664.7 68.9%  
Dividends per share (Unadj.) Rs10.0012.70 78.7%  
Dividend yield (eoy) %1.00.9 110.7%  
Book value per share (Unadj.) Rs201.8292.9 68.9%  
Shares outstanding (eoy) m265.47119.57 222.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.63.4 193.9%   
Avg P/E ratio x25.125.1 100.2%  
P/CF ratio (eoy) x22.521.8 103.2%  
Price / Book Value ratio x5.04.8 103.2%  
Dividend payout %25.022.6 111.0%   
Avg Mkt Cap Rs m266,266168,653 157.9%   
No. of employees `0009.7NA-   
Total wages/salary Rs m4,6879,171 51.1%   
Avg. sales/employee Rs Th4,175.0NM-  
Avg. wages/employee Rs Th481.5NM-  
Avg. net profit/employee Rs Th1,089.3NM-  
INCOME DATA
Net Sales Rs m40,64349,915 81.4%  
Other income Rs m7491,645 45.5%   
Total revenues Rs m41,39251,561 80.3%   
Gross profit Rs m14,4608,482 170.5%  
Depreciation Rs m1,2331,006 122.6%   
Interest Rs m23671 3.4%   
Profit before tax Rs m13,9538,451 165.1%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,3491,606 208.5%   
Profit after tax Rs m10,6046,731 157.5%  
Gross profit margin %35.617.0 209.4%  
Effective tax rate %24.019.0 126.3%   
Net profit margin %26.113.5 193.5%  
BALANCE SHEET DATA
Current assets Rs m40,10527,062 148.2%   
Current liabilities Rs m6,59515,324 43.0%   
Net working cap to sales %82.523.5 350.6%  
Current ratio x6.11.8 344.4%  
Inventory Days Days11967 178.2%  
Debtors Days Days8141 195.5%  
Net fixed assets Rs m19,99512,610 158.6%   
Share capital Rs m531239 222.0%   
"Free" reserves Rs m53,04334,490 153.8%   
Net worth Rs m53,57435,027 153.0%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m61,58554,387 113.2%  
Interest coverage x618.413.6 4,546.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.9 71.9%   
Return on assets %17.313.6 126.8%  
Return on equity %19.819.2 103.0%  
Return on capital %26.124.9 104.9%  
Exports to sales %012.9 0.0%   
Imports to sales %25.23.1 818.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs m10,2591,540 666.1%   
Fx inflow Rs m35,3846,563 539.1%   
Fx outflow Rs m10,3993,012 345.3%   
Net fx Rs m24,9853,552 703.5%   
CASH FLOW
From Operations Rs m11,4937,259 158.3%  
From Investments Rs m-11,3721,864 -610.0%  
From Financial Activity Rs m-93-9,273 1.0%  
Net Cashflow Rs m28-150 -18.9%  

Share Holding

Indian Promoters % 52.0 66.9 77.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 33.1 35.6%  
FIIs % 19.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 0.0 -  
Shareholders   31,796 68,381 46.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare DIVIS LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Feb 21, 2018 11:33 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - NATCO PHARMA COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS